Joshua S. Benner, PHARMD, SCD – Chief Executive Officer at RxAnte
Josh Benner is the Founder and CEO of RxAnte, a pioneering provider of advanced analytics, patented technology, and high-touch pharmacy services that get more from medicines. The company’s solutions increase quality scores and lower costs by improving prescription drug use in medically complex and vulnerable populations. A leading voice on medication adherence, Dr. Benner’s award-winning research, and numerous publications have shed new light on the problem of non-adherence and identified promising approaches to improving it.
Prior to RxAnte, Dr. Benner was a Fellow and Managing Director at the Brookings Institution’s Engelberg Center for Health Care Reform where he focused on medical technology policy. Prior to Brookings, Dr. Benner was the principal at ValueMedics Research, an analytic and consulting services firm. Following the sale of ValueMedics to IMS Health in 2007, he served as senior principal in health economics and outcomes research and global lead for medication adherence at IMS (now IQVIA).
Dr. Benner received his Doctor of Pharmacy degree from Drake University and his Doctor of Science in health policy and management from the Harvard University School of Public Health. He was a post-doctoral fellow in health services research at the Brigham and Women’s Hospital Department of Pharmacoepidemiology and Pharmacoeconomics. Dr. Benner is currently a member of the Health Policy and Management Executive Council at the Harvard T.H. Chan School of Public Health, and an Entrepreneur in Residence at the Harvard i-lab.